Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle

Endocrinology

Volumn 151, Issue 5, 2010, Pages 2140-2150

  Tammali, Ravinder ^a   Saxena, Ashish ^a   Srivastava, Satish K ^a   Ramana, Kota V ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROXYNONANE; ALDEHYDE DERIVATIVE; ALDEHYDE REDUCTASE; CELL NUCLEUS ANTIGEN; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; GLUCOSE; GLUTATHIONE; GLUTATHIONE DERIVATIVE; GLUTATHIONYL 1,4 DIHYDROXYNONANE; HYDROXY 2 NONENAL; POLYOL; REACTIVE OXYGEN METABOLITE; RETINOBLASTOMA PROTEIN; SORBINIL; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYCLINE; E2F1 PROTEIN, RAT; IMIDAZOLIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME INHIBITION; MALE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; CELL CYCLE; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ALDEHYDE REDUCTASE; ANIMALS; AORTA; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYCLINS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; E2F1 TRANSCRIPTION FACTOR; G1 PHASE; GLUCOSE; IMIDAZOLIDINES; MALE; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; S PHASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953169082     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0160     Document Type: Article

References (42)

1. Krolewski AS, Warram JH, Rand LI, Kahn CR 1987 Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 317:1390-1398
2. Srivastava SK, Ramana KV, Bhatnagar A 2005 Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 26:380-392 (Pubitemid 40691299)
3. Srivastava S, Ramana KV, Tammali R, Srivastava SK, Bhatnagar A 2006 Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells. Diabetes 55:901-910
4. Barsness GW, Peterson ED, Ohman EM, Nelson CL, DeLong ER, Reves JG, Smith PK, Anderson RD, Jones RH, Mark DB, Califf RM 1997 Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 96:2551-2556
5. Van Belle E, Ketelers R, Bauters C, Périé M, Abolmaali K, Richard F, Lablanche JM, McFadden EP, Bertrand ME 2001 Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: a key determinant of survival in diabetics after coronary balloon angioplasty. Circulation 103:1218-1224
6. Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Aggarwal BB, Srivastava SK 2002 Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells. J Biol Chem 277:32063-32070
7. Sheetz MJ, King GL 2002 Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288:2579-2588
8. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, SteffesMW 2005 Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med 165:1910-1916 (Pubitemid 41352087)
9. Clausell N, Kalil P, Biolo A, Molossi S, Azevedo M 1999 Increased expression of tumor necrosis factor-α in diabetic macrovasculopathy. Cardiovasc Pathol 8:145-151
10. Rayment NB, Moss E, Faulkner L, Brickell PM, Davies MJ, Woolf N, Katz DR 1996 Synthesis of TNFα and TGFβ mRNA in the different micro-environments within atheromatous plaques. Cardiovasc Res 32:1123-1130
11. Braun-Dullaeus RC, Mann MJ, Dzau VJ 1998 Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation 98:82-89
12. Walker LN, Bowen-Pope DF, Ross R, Reidy MA 1986 Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci USA 83:7311-7315
13. Warner SJ, Libby P 1989 Human vascular smooth muscle cells: target for and source of tumor necrosis factor. J Immunol 142:100-109 (Pubitemid 19034728)
14. Ramana KV, Bhatnagar A, Srivastava SK 2004 Aldose reductase regulates TNF-α-induced cell signaling and apoptosis in vascular endothelial cells. FEBS Lett 570:189-194
15. Elkind MS, Cheng J, Boden-Albala B, Rundek T, Thomas J, Chen H, Rabbani LE, Sacco RL 2002 Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke 33:31-37
16. Lee SO, Jeong YJ, Yu MH, Lee JW, Hwangbo MH, Kim CH, Lee IS 2006 Wogonin suppresses TNF-α-induced MMP-9 expression by blocking the NF-κB activation via MAPK signaling pathways in human aortic smooth muscle cells. Biochem Biophys Res Commun 351:118-125
17. Ramana KV, Bhatnagar A, Srivastava S, Yadav UC, Awasthi S, Awasthi YC, Srivastava SK 2006 Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy- trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth. J Biol Chem 281:17652-17660
18. Ramana KV, Tammali R, Reddy AB, Bhatnagar A, Srivastava SK 2007 Aldose reductase-regulated tumor necrosis factor-α production is essential for high glucose-induced vascular smooth muscle cell growth. Endocrinology 148:4371-4384
19. Ahn JD, Morishita R, Kaneda Y, Kim HS, Chang YC, Lee KU, Park JY, Lee HW, Kim YH, Lee IK 2002 Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia. Gene Ther 9:1682-1692 (Pubitemid 36104612)
20. Kim MJ, Park KG, Lee KM, Kim HS, Kim SY, Kim CS, Lee SL, Chang YC, Park JY, Lee KU, Lee IK 2005 Cilostazol inhibits vascular smooth muscle cell growth by down regulation of the transcription factor E2F. Hypertension 45:552-556
21. Salam MA, Matin K, Matsumoto N, Tsuha Y, Hanada N, Senpuku H2004 E2f1 mutation induces early onset of diabetes and Sjögren's syndrome in nonobese diabetic mice. J Immunol 173:4908-4918
22. Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A 1992 A cDNA encoding a pRB-binding protein with properties of transcription factor E2F. Cell 70:337-350
23. Shan B, Lee WH 1994 Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 14:8166-8173 (Pubitemid 24373565)
24. Nevins JR 1992 E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429
25. Hahm ER, Singh SV 2007 Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Mol Cancer Ther 6:2686-2695
26. Wang W, Dong L, Saville B, Safe S 1999 Transcriptional activation of E2F1 gene expression by 17β-estradiol in MCF-7cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Mol Endocrinol 13: 1373-1387 (Pubitemid 30645293)
27. Tammali R, Ramana KV, Singhal SS, Awasthi S, Srivastava SK 2006 Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells. Cancer Res 66:9705-9713
28. Rao GN, Berk BC 1992 Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 70:593-599
29. Elouil H, Cardozo AK, Eizirik DL, Henquin JC, Jonas JC 2005 High glucose and hydrogen peroxide increase c-Myc and haeme-oxygenase 1 mRNA levels in rat pancreatic islets without activating NFκB. Diabetologia 48:496-505
30. Hwang YC, Kaneko M, Bakr S, Liao H, Lu Y, Lewis ER, Yan S, Ii S, Itakura M, Rui L, Skopicki H, Homma S, Schmidt AM, Oates PJ, Szabolcs M, Ramasamy R 2004 Central role for aldose reductase pathway in myocardial ischemic injury. FASEB J 18:1192-1199 (Pubitemid 39006881)
31. Kaiserova K, Srivastava S, Hoetker JD, Awe SO, Tang XL, Cai J, Bhatnagar A 2006 Redox activation of aldose reductase in the ischemic heart. J Biol Chem 281:15110-15120
32. Ruef J, Liu SQ, Bode C, Tocchi M, Srivastava S, Runge MS, Bhatnagar A 2000 Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury. Arterioscler Thromb Vasc Biol 20:1745-1752
33. Tammali R, Ramana KV, Srivastava SK 2007 Aldose reductase regulates TNF-α-induced PGE2 production in human colon cancer cells. Cancer Lett 252:299-306
34. Ramana KV, Willis MS, White MD, Horton JW, DiMaio JM, Srivastava D, Bhatnagar A, Srivastava SK 2006 Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition. Circulation 114:1838-1846
35. Cobrinik D 2005 Pocket proteins and cell cycle control. Oncogene 24:2796-2809 (Pubitemid 40638091)
36. Maiti B, Li J, de Bruin A, Gordon F, Timmers C, Opavsky R, Patil K, Tuttle J, Cleghorn W, Leone G 2005 Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation. J Biol Chem 280:18211-18220
37. Féliers D, Frank MA, Riley DJ 2002 Activation of cyclin D1-Cdk4 and Cdk4-directed phosphorylation of RB protein in diabetic mesangial hypertrophy. Diabetes 51:3290-3299
38. Lee B, Moon SK 2005 Resveratrol inhibits TNF-α-induced proliferation and matrix metalloproteinase expression in human vascular smooth muscle cells. J Nutr 135:2767-2773
39. Suh SJ, Jin UH, Kim SH, Chang HW, Son JK, Lee SH, Son KH, Kim CH 2006 Ochnaflavone inhibits TNF-α-induced human VSMC proliferation via regulation of cell cycle, ERK1/2, and MMP-9.J Cell Biochem 99:1298-1307
40. Ramana KV, Fadl AA, Tammali R, Reddy AB, Chopra AK, Srivastava SK 2006 Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages. J Biol Chem 281:33019-33029
41. Kim YH, Heo JS, Han HJ 2006 High glucose increase cell cycle regulatory proteins level of mouse embryonic stem cells via PI3-K/Akt and MAPKs signal pathways. J Cell Physiol 209:94-102
42. Kipshidze NN, Kim HS, Iversen P, Yazdi HA, Bhargava B, New G, Mehran R, Tio F, Haudenschild C, Dangas G, Stone GW, Iyer S, Roubin GS, Leon MB, Moses JW 2002 Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model. J Am Coll Cardiol 39: 1686-1691